Read the latest positive news, breakthroughs, and inspiring stories about psilocybin research, curated daily by BrightWire.
A Swedish study found that one 25mg dose of psilocybin rapidly reduced depression symptoms in patients who hadn't responded well to traditional treatments. While the advantage over placebo faded after a year, more than half who received psilocybin achieved remission within six weeks.
After years of debilitating headaches and brain fog, Elizabeth Richwine found relief through a clinical trial using psilocybin therapy in Baltimore. Her story reflects growing medical research showing psychedelics may help treat chronic conditions when traditional medicine falls short.
A Virginia medical center just received over $600,000 to study whether psychedelic therapy could help people break free from cocaine addiction. Patients there will have access to treatment available at only a handful of facilities nationwide.
A groundbreaking clinical trial will explore whether psilocybin therapy could help people overcome cocaine addiction, a disorder that currently has no FDA-approved treatment. The research could open new doors for thousands struggling with stimulant use disorders.
The U.S. Department of Veterans Affairs is testing psilocybin therapy for veterans whose depression hasn't responded to traditional treatments. The groundbreaking PIVOT trial will serve veterans at five locations nationwide, offering new hope for those who've exhausted other options.
University of South Florida researchers are running clinical trials using psilocybin to help people with serious mental health conditions. The studies could open new treatment paths for patients who haven't found relief through traditional therapies.